Business
Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA
Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA

About this update from Jamjoom Pharmaceuticals Factory Co.
JAMJOOM PHARMACEUTICALS FACTORY COMPANY SJSC TADAWUL:4015:JAMJOOM PHARMA - STRIKES STRATEGIC DEAL WITH BIO-THERA FOR SECURING COSENTYX BIOSIMILAR IN MENAJAMJOOM PHARMA - UNDER DEAL, CO WILL OBTAIN EXCLUSIVE RIGHTS TO COMMERCIALIZE BAT2306 ACROSS MENA REGIONJAMJOOM PHARMA WILL MANAGE REGULATORY SUBMISSIONS, MARKET ACCESS, AND COMMERCIALIZATION IN MENABIO-THERA WILL OVERSEE PRODUCT DEVELOPMENT AND GLOBAL MANUFACTURING FROM ITS STATE-OF-THE-ART FACILITIES IN GUANGZHOU, CHINA
View stock analysis, news, and events for Jamjoom Pharmaceuticals Factory Co.